PATENT CLAIM ANALYSIS

Application Number: 16426905
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-10
Patent Classification: ["435", "325000"]

Abstract:
Compositions comprising synthetic membrane-receiver complexes, methods of generating synthetic membrane-receiver complexes, and methods of treating or preventing diseases, disorders or conditions therewith.

Claim (Index 29):
A method of reducing arginine levels in a subject, comprising administering to the subject the pharmaceutical composition of  claim 22 , thereby reducing arginine levels in the subject.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 100.0
- Lexical Diversity: 1.44444
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16409576', '15925212', '16195811', '15783921', '15824877']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7015756374598593
- 35 USC 102 Novelty (BERT): 0.6039864240923991
- Combined Prediction Score: 0.6918167161231132
- Mean Citation Score: 616.8888920000003
- Max Citation Score: 628.19305
- Similarity Product: 449.6679160939068

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test